PDA

View Full Version : SCI (Related) Research

  1. Naish, et al. (2003). Ultrasound imaging of the intervertebral disc.
  2. Norcross, et al. (2003). An in vivo model of degenerative disc disease.
  3. Kroeber, et al. (2002). New in vivo animal model to create intervertebral disc degeneration and to investigate the effects of therapeutic strategies to stimulate disc regeneration.
  4. Ngo, et al. (2003). Poly(L-Lactide) microfilaments enhance peripheral nerve regeneration across extended nerve lesions.
  5. Calvillo, et al. (2003). Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.
  6. Yu, et al. (2003). Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump.
  7. Moreno-Flores, et al. (2003). High level of amyloid precursor protein expression in neurite-promoting olfactory ensheathing glia (OEG) and OEG-derived cell lines.
  8. van den Pol & Santarelli (2003). Olfactory ensheathing cells: time lapse imaging of cellular interactions, axonal support, rapid morphologic shifts, and mitosis.
  9. Melatonin & scoliosis
  10. Kapur & Shoichet (2003). Chemically-bound nerve growth factor for neural tissue engineering applications.
  11. Heinrich, et al. (2003). Principles of IL-6-type cytokine signalling and its regulation.
  12. Shaw & Shoichet (2003). Toward spinal cord injury repair strategies: peptide surface modification of expanded poly(tetrafluoroethylene) fibers for guided neurite outgrowth in vitro.
  13. Moreno-Flores, et al. (2003). Immortalized olfactory ensheathing glia promote axonal regeneration of rat retinal ganglion neurons.
  14. Lipson, et al. (2003). Neurotrophic properties of olfactory ensheathing glia.
  15. Au & Roskams (2003). Olfactory ensheathing cells of the lamina propria in vivo and in vitro.
  16. Vincent, et al. (2003). Morphological plasticity of olfactory ensheathing cells is regulated by cAMP and endothelin-1.
  17. Erbayraktar, et al. (2003). Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.
  18. Scheepens, et al. (2003). A delayed increase in hippocampal proliferation following global asphyxia in the neonatal rat.
  19. Hartgens, et al. (2003). Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes.
  20. Estrada, et al. (2003). Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a g protein-coupled receptor in skeletal muscle cells.
  21. Uhlen, et al. (2003). Nandrolone treatment decreases the level of rat kidney alpha(1B)-adrenoceptors.
  22. Kindlundh, et al. (2003). Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain.
  23. Crawford, et al. (2003). Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment.
  24. Menon (2003). Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin.
  25. Schroeder, et al. (2003). Androgen therapy improves muscle mass and strength but not muscle quality: results from two studies.
  26. Kasantikul, et al. (2003). Head and neck injuries in fatal motorcycle collisions...
  27. Kirihara, et al. (2003). Comparative Neurotoxicity of Intrathecal and Epidural Lidocaine in Rats.
  28. Tyler, et al. (2003). Origins and early descriptions of "Duchenne muscular dystrophy".
  29. Xing, et al. (2003). The use of the potassium channel activator riluzole to test whether potassium
  30. Kiehn & Butt (2003). Physiological, anatomical and genetic identification of CPG neurons in the dev
  31. Seattle Area Paid Study For S.C.I. Patients & Physicians
  32. Qi, et al. (2003). Evidence that the notochord may be pivotal in the development of sacral and anor
  33. Thibert, et al. (2003). Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog.
  34. Jacob & Briscoe (2003). Gli proteins and the control of spinal-cord patterning.
  35. Shimizu, et al. (2003). [Regulation of development of oligodendrocyte]
  36. Qi, et al. (2003). Gli2 is required for normal Shh signaling and oligodendrocyte development in the
  37. Motoyama, et al. (2003). Differential requirement for Gli2 and Gli3 in ventral neural cell fate spe
  38. Charron, et al. (2003). The morphogen sonic hedgehog is an axonal chemoattractant that collaborates
  39. Wijgerde, et al. (2003). A direct requirement for Hedgehog signaling for normal specification of al
  40. Yourick, et al. (2003). N-acetylaspartylglutamate and beta-NAAG ...spinal cord cultures
  41. Glomsda, et al. (2003). Inhibition...monocyte...adhesion molecule...immunosuppressant mycophenolate
  42. Garrido, et al. (2003). Nicotine upregulates nerve growth factor... prevents apoptosis... neurons
  43. Yonezawa, et al. (2003). Limitrin, a novel immunoglobulin superfamily protein localized to glia lim
  44. Murphy, et al. (2003). Explaining labor force status following spinal cord injury...
  45. Velez, et al. (2003). [4-aminopyridine poisoning in a pediatric case]
  46. Neurobiology: A move to sort life from death
  47. Webster, et al. (2004). Work-related tetraplegia: cause of injury and annual medical costs.
  48. Young, et al. (2004). Services provided following compensable work-related tetraplegia.
  49. Lucke, et al. (2004). Quality of life in spinal cord injured individuals and their caregivers
  50. Price, et al. (2004). Perceived quality of life and function in chronic SCI
  51. LoPresti, et al. (2004). Adaptive software for head-operated computer controls.
  52. Mason, et al. (2003). Increased growth genes by cortical neurons after brain but not cord injury
  53. Bomze, et al. (2001). Spinal cord regeneration in mice overexpressing GAP-43 and CAP-23
  54. Mason, et al. (2002). Increased SCG10, CAP-23 expression in regrowing peripheral & central neurons
  55. Gianola, et al. (2004). GAP-43 overexpression overrides inhibition from myelin-associated proteins
  56. sweating
  57. Deumens, et al. (2004). Glial alignment directs neurite growth in culture
  58. Balmer & LaMantia (2004). GLi3 & Shh loss disrupts olfactory axon trajectories
  59. Lacroix, et al. (2004). Corticospinal tracts in macaque monkey
  60. Meng, et al. (2004). ...transition from development to motor control...
  61. Durrenberger, et al. (2004). COX-2 in injured human nerve and rat nerve injury
  62. Jinks, et al. (2004). Isoflurane Differentially Modulates Medullary ON and OFF Neurons
  63. Hunt, et al. (2004). ATF3 upregulation in glia during Wallerian degeneration
  64. Hetman, et al. (2004). ERK-1 and 2 in neuronal survival.
  65. Edelstein, et al. (2004). Gene therapy clinical trials worldwide 1989-2004
  66. McMahon & Wells (2004). Electroporation for gene transfer to skeletal muscles
  67. Ebensen, et al. (2004). Bacterial ghosts are an efficient delivery system for DNA vaccines.
  68. Nardone, et al. (2004). Motor cortical excitability changes in humans after oral theophylline
  69. Kawai, et al. (2004). Increase in BrDU positive neurons after transient brain ischemia
  70. Ribeiro, et al. (2004). Low intensity ppolarized laser enhances skin healing
  71. Kastin & Pan (2005). Targetting neurite growth inhibitors
  72. Garcia-Overjero, et al. (2005). Neuroprotective steroid hormones
  73. Byrnes, et al. (05): Laser alters olfactory ensheathing glial gene expression
  74. Woodhouse, et al. (2005): Spinal cord tissues affect OEG in culture
  75. Liu, et al. (2005). The mitosis and immunocytochemistry of olfactory ensheathing cells from nasal olfactory mucosa.
  76. howard hughes
  77. Russian study
  78. Study for Kids in NJ (SCI)
  79. Electromyography
  80. The Real Predictors of Disposition in Patients with Spinal Cord Injuries
  81. Rapid diagnosis of UTI's
  82. The Power of Hope
  83. Use of complementary and alternative medicine practitioners by people with physical d
  84. Feridex
  85. Construct validity and dimensional structure of the ASIA motor scale
  86. Neuronal cell cultures kept on the straight and narrow
  87. Psychological research
  88. Psych research 2
  89. Psych 3
  90. Syringomyelia: Current Concepts in the Pathogenesis, Diagnosis , and Treatment
  91. SAMe and Remyelination
  92. Complementary and alternative therapies: the nurse's role.
  93. Current trends in the treatment of infertility in men with spinal cord injury
  94. Migration of Neural Stem Cells Toward a Site of Spinal Cord Injury
  95. Involvement of IGF-1/LARG Signaling in the Differentiation of Neural Stem Cells into
  96. Repairing the spinal cord from within - 4part UW video
  97. Clinical management for spontaneous spinal epidural hematoma
  98. The Kentucky Spinal Cord Injury Research Center
  99. Video: X-irradiation & Tempol improves locomotor function in animal model
  100. Could Neurotrophins Replace Treadmill Training as Locomotor Therapy Following Spinal
  101. Plasticity of interneuronal networks
  102. Some historical reflections on the neural control of locomotion
  103. Spinal Cord Injury May Not Increase Risk of Heart Disease
  104. Article: EPO comparison with Methylprednisolone
  105. A select combination of neurotrophins enhances neuroprotection and functional recover
  106. Article on Lithium and Engraftment
  107. Chondroitinase
  108. Serious injuries, alcohol and young macho men
  109. Targeting MMPs in acute and chronic neurological conditions.
  110. Will the SCI/ABI community benefit from war?
  111. A molecular platform in neurons regulates inflammation after spinal cord injury
  112. Biocompatible hydrogels in spinal cord injury repair.
  113. CD133+ cells from human peripheral blood promote corticospinal axon regeneration.
  114. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation
  115. Treatments for spinal cord injury: Is there hope in neurosteroids?
  116. DNA polymorphisms as tools for spinal cord injury research.
  117. Devices for Increasing Independence
  118. Incidence of SCI and TBI
  119. The cell culture expansion of bone marrow stromal cells from humans with SCI
  120. Neuroregenerative effects: lentiviral vector-mediated GDNF expression in ventral root
  121. Customizable selection of shoulder and elbow muscles for a C5 SCI neuroprosthesis.
  122. Biocompatible hydrogels in spinal cord injury repair.
  123. Thermoresponsive hydrogel scaffolds for the repair of spinal cord injury.
  124. Acute and delayed implantation of positively charged 2-hydrogels
  125. Chronic Pain Treatment
  126. The Flock Method
  127. Allen Spinal Cord Atlas
  128. Glutamine synthetase protects the spinal cord against hypoxia
  129. Synthetic stem cell culture plate
  130. BDNF-exercise interactions in the recovery of symmetrical stepping
  131. DNA polymorphisms as tools for spinal cord injury research.
  132. using healthy muscles to control electrical implants to stimulate muscles
  133. Clinical practice of functional electrical stimulation: from "Yesterday" to "Today".
  134. Davies Article
  135. Scientists coax brain cells in mice to regenerate
  136. Brain motor system function following extensive brain-computer interface training.
  137. The effectiveness of physical interventions for people with spinal cord injuries
  138. Light-induced rescue of breathing after spinal cord injury.
  139. Simultaneous isolation of vascular endothelial and mesenchymal stem cells from HUCSC
  140. traumatic injury study by OT graduate student
  141. In this issue.
  142. Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
  143. hUCB and Tissue Plasminogben Activator Levels
  144. GDNF-enhanced axonal regeneration and myelination following spinal cord injury
  145. Using Light to Reinstate Respiratory Plasticity.
  146. The bright side of the glial scar in CNS repair.
  147. Locomotor Recovery after Spinal Cord Lesions in the Lamprey
  148. BDNF-expressing marrow stromal cells support extensive axonal growth
  149. The role of biodegradable engineered scaffolds seeded with Schwann cells
  150. Progesterone neuroprotection in traumatic cns injury and motoneuron degeneration.
  151. Over comming myelin-mediated inhibition of oligodendrocyte precursor differentiation
  152. Response of Ependymal Progenitors to Spinal Cord Injury or Enhanced Physical Activity
  153. High-dose corticosteroids after SCI reduce neural progenitor cell proliferation
  154. Distributed neural networks for controlling human locomotion
  155. A review of published reports on neuroprotection in spinal cord injury.
  156. Cellular approaches to CNS remyelination stimulation
  157. A web-based computer program to determine the ASIA impairment classification.
  158. Toll-like receptors in spinal cord injury.
  159. Transplantation of dendritic cells promotes functional recovery from SCI in marmoset
  160. A review of published reports on neuroprotection in spinal cord injury.
  161. Promising Therapeutic Target For Central Nervous System Injuries Identified
  162. Current & future applications of transcriptomics for discovery in CNS disease & injur
  163. Promoting axonal myelination for improving neurological recovery in SCI
  164. Disuse Atrophy of Human Skeletal Muscle: Cell Signaling and Potential Interventions.
  165. Spinal cord repair: bridging the divide.